Cardiovascular/Lipid Condition | Significant positive association found | Significant negative association found | No significant association found |
---|---|---|---|
CVD | Kahn et al. 1977 [104], Hyman et al. 1983 [117], Tan et al. 2007 [118], Fernandez et al. 2012 [124], Wu et al. 2014 [125] | Eye Disease Case–control Study Group 1992 [107], Klein et al. 1993 [108], Smith et al. 2001 [110], Klein et al. 2003 [109], Tomany et al. 2004 [111], Klein et al. 2007 [112], Fraser-Bell et al. 2008 [113], Golan et al. 2011 [116], Erke et al. 2014 [115] | |
Cardiovascular mortality | |||
MI | Nguyen-Khoa et al. 2008 [130] | ||
CHD | Wong et al. 2007 [122], Sun et al. 2009 [123], Fernandez et al. 2012 [124], Wu et al. 2014 [125], Yang et al. 2014 [127] | Delcourt et al. 2001 [129] | |
CAD | |||
Atherosclerosis | van Leeuwen et al. 2003 [132], Klein et al. 2007 [133], Taniguchi et al. 2015 [134] | Klein et al. 2003 [131] | |
Stroke | Tan et al. 2007 [118], Fraser-Bell et al. 2008 [113], Tan et al. 2008 [137], Liao et al. 2008 [135], Hu et al. 2010 [136], Wieberdink et al. 2011 [138], Ikram et al. 2012 [139], Wu et al. 2014 [125] | Smith et al. 2001 [110], Delcourt et al. 2001 [129], Klein et al. 2003 [109], Tomany et al. 2004 [111], Klein et al. 2007 [112], Sun et al. 2009 [123], Erke et al. 2014 [115] | |
Hypertension | Kahn et al. 1977 [104], Sperduto & Hiller 1986 [144], Hyman et al. 2000 [145], Yang et al. 2014 [127], Cheung et al. 2014 [148], Thomas et al. 2015 [126] | Klein et al. 1993 [108], Smith et al. 2001 [110], Delcourt et al. 2001 [129], Klein et al. 2003 [131], Tomany et al. 2004 [111], Tan et al. 2007 [118], Fraser-Bell et al. 2008 [113], Yip et al. 2015 [147] | |
Diastolic blood pressure | Vidaurri et al. 1984 [143], Hyman et al. 2000 [145], Fraser-Bell et al. 2008 [113] | van Leeuwen et al. 2003 [132] | |
Systolic blood pressure | Klein et al. 2003 [109], van Leeuwen et al. 2003 [132], Erke et al. 2014 [115] | ||
Pulse pressure | Klein et al. 2003 [109], van Leeuwen et al. 2003 [132], Fraser-Bell et al. 2008 [113], Cougnard-Grégoire et al. 2013 [146] | Fraser-Bell et al. 2008 [113] | |
Total serum cholesterol | Eye Disease Case–control Study Group 1992 [107], Tomany et al. 2004 [111], Ulaş et al. 2013 [149] | Klein et al. 1993 [108], Klein et al. 2003 [131], Tomany et al. 2004 [111], Cheung et al. 2014 [148] | Smith et al. 2001 [110], Delcourt et al. 2001 [129], Abalain et al. 2002 [151], Tan et al. 2007 [118], Munch et al. 2013 [153], Erke et al. 2014 [115], Mulero et al. 2014 [152], Klein et al. 2014 [53], Cheung et al. 2014 [148] |
HDL-C | Klein et al. 1993 [108], Delcourt et al. 2001 [129], Klein et al. 2003 [109], Tomany et al. 2004 [111], Tan et al. 2007 [118], Cougnard-Grégoire et al. 2014 [150] | Smith et al. 2001 [110], Abalain et al. 2002 [151], Tan et al. 2007 [118], Erke et al. 2014 [115], Mulero et al. 2014 [152], Klein et al. 2014 [53], Cheung et al. 2014 [148] | |
LDL-C | Ulaş et al. 2013 [149] | Abalain et al. 2002 [151], Tan et al. 2007 [118], Erke et al. 2014 [115], Mulero et al. 2014 [152], Cheung et al. 2014 [148] | |
Cholesterol intake | Hyman et al. 2000 [145], | ||
HDL | Munch et al. 2013 [153] | ||
LDL | Munch et al. 2013 [153] | ||
Total cholesterol/HDL-C ratio | Tan et al. 2007 [118] | Klein et al. 1993 [108] | |
Hyperlipidemia | Vassilev et al. 2015 [120] | ||
Triglycerides | Munch et al. 2013 [153] | Delcourt et al. 2001 [129], Abalain et al. 2002 [151], Tan et al. 2007 [118], Munch et al. 2013 [153], Erke et al. 2014 [115], Mulero et al. 2014 [152], Yip et al. 2015 [147] | |
Phospholipids | Abalain et al. 2002 [151] | ||
BMI | Klein et al. 2007 [112], Delcourt et al. 2001 [129], Ulaş et al. 2013 [149], Erke et al. 2014 [115] | Smith et al. 2001 [110], Tomany et al. 2004 [111], DeAngelis et al. 2004 [154], Tan et al. 2007 [118], Munch et al. 2013 [153], Cheung et al. 2014 [148] | |
Physical exercise | Klein et al. 2003 [109], Munch et al. 2013 [153], Erke et al. 2014 [115] | ||
Waist circumference | Munch et al. 2013 [153] | Erke et al. 2014 [115] | |
Waist-to-hip ratio | Erke et al. 2014 [115] | ||
Serum carotenoid levels | Eye Disease Case–control Study Group 1992 [107] | ||
Dietary lutein/zeazanthin | SanGiovanni 2007 [160], SanGiovanni et al. 2008 [161], Bonds et al. 2014 [163], Chew et al. 2014 [164], Wu et al. 2015 [162] | ||
Dietary DHA/EPA | SanGiovanni 2007 [160], SanGiovanni et al. 2008 [161], Wu et al. 2015 [162] | ||
Statin use | Klein et al. 2003 [173] | Hall et al. 2001 [165], McCarty et al. 2001 [166], Wilson et al. 2004 [167], McGwin et al. 2005 [168], Guymer at al. 2008 [175], Guymer et al. 2013 [176], Sasaki et al. 2013 [177], Ma et al. 2015 [174], Vavvas et al. 2016 [180] | Klein et al. 2007 [112], Cougnard-Grégoire et al. 2013 [146], McGwin et al. 2006 [170], Maguire et al. 2009 [171], Shalev et al. 2011 [114], Klein et al. 2014 [53], Al-Holou et al. 2015 [172] |
Female Sex | Hirvelä et al. 1996 [189], AREDS Group 2000 [185], Buch et al. 2005 [184], Roh et al. 2008 [186], Laitinen et al. 2010 [183], Fong & Contreras 2010 [188], Chakravarthy et al. 2010 [190], You et al. 2012 [187] | ||
Hormone therapy | Eye Disease Case–control Study Group 1992 [107], van Leeuwen et al. 2004 [194] | ||
Age at menarche | Snow et al. 2002 [182] | ||
Age at menopause | Tomany et al. 2004 [111] | ||
Time from menarche to menopause | Tomany et al. 2004 [111] |